KPJ Healthcare Berhad Crescita futura

Future criteri di controllo 3/6

KPJ Healthcare Berhad prevede che gli utili e i ricavi cresceranno rispettivamente di 11.5% e 6.4% all'anno. Si prevede che l'EPS crescerà di 10.5% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 13.5% in 3 anni.

Informazioni chiave

11.5%

Tasso di crescita degli utili

10.5%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	2.6%
Tasso di crescita dei ricavi	6.4%
Rendimento futuro del capitale proprio	13.5%
Copertura analitica	Good
Ultimo aggiornamento	29 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

We Think KPJ Healthcare Berhad (KLSE:KPJ) Can Stay On Top Of Its Debt

Dec 18

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Nov 07

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Jun 24

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

Jun 02

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

Mar 25

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Mar 11

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Feb 14

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Jan 23

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Jan 09

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

Jun 06

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

May 03

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Mar 07

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 20

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Jan 31

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

Sep 15

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 01

Previsioni di crescita degli utili e dei ricavi

KLSE:KPJ - Stime future degli analisti e dati finanziari passati (MYR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	4,379	386	524	747	15
12/31/2025	4,096	353	512	724	15
12/31/2024	3,792	311	439	733	15
9/30/2024	3,783	298	358	684	N/A
6/30/2024	3,657	304	370	639	N/A
3/31/2024	3,512	303	350	591	N/A
12/31/2023	3,419	281	417	658	N/A
9/30/2023	3,236	276	364	583	N/A
6/30/2023	3,128	235	324	548	N/A
3/31/2023	3,042	211	282	527	N/A
12/31/2022	2,868	179	226	460	N/A
9/30/2022	2,792	122	284	555	N/A
6/30/2022	2,692	84	250	485	N/A
3/31/2022	2,626	64	225	470	N/A
12/31/2021	2,590	55	195	412	N/A
9/30/2021	2,560	58	122	368	N/A
6/30/2021	2,495	79	128	386	N/A
3/31/2021	2,338	85	93	307	N/A
12/31/2020	2,397	110	95	337	N/A
9/30/2020	1,853	169	160	415	N/A
6/30/2020	2,138	182	110	446	N/A
3/31/2020	2,523	211	132	535	N/A
12/31/2019	2,738	211	177	581	N/A
9/30/2019	3,581	180	148	604	N/A
6/30/2019	3,483	176	167	560	N/A
3/31/2019	3,424	176	174	543	N/A
12/31/2018	3,366	179	131	518	N/A
9/30/2018	3,279	188	3	381	N/A
6/30/2018	3,246	177	N/A	296	N/A
3/31/2018	3,224	168	N/A	359	N/A
12/31/2017	3,180	166	N/A	362	N/A
9/30/2017	3,040	161	N/A	279	N/A
6/30/2017	3,018	162	N/A	391	N/A
3/31/2017	3,005	160	N/A	239	N/A
12/31/2016	2,970	154	N/A	143	N/A
9/30/2016	2,978	124	N/A	187	N/A
6/30/2016	2,933	130	N/A	115	N/A
3/31/2016	2,882	136	N/A	192	N/A
12/31/2015	2,848	135	N/A	189	N/A
9/30/2015	2,862	158	N/A	338	N/A
6/30/2015	2,798	149	N/A	322	N/A
3/31/2015	2,746	147	N/A	339	N/A
12/31/2014	2,639	143	N/A	319	N/A
9/30/2014	2,556	126	N/A	270	N/A
6/30/2014	2,464	117	N/A	174	N/A
3/31/2014	2,389	108	N/A	140	N/A
12/31/2013	2,332	103	N/A	144	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di KPJ ( 11.5% all'anno) è superiore al tasso di risparmio ( 3.6% ).

Guadagni vs Mercato: Si prevede che gli utili di KPJ ( 11.5% all'anno) cresceranno più rapidamente del mercato MY ( 10.3% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di KPJ cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di KPJ ( 6.4% all'anno) crescerà più rapidamente del mercato MY ( 6.3% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di KPJ ( 6.4% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di KPJ sarà basso tra 3 anni ( 13.5 %).

Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

Dati	Ultimo aggiornamento (ora UTC)
Analisi dell'azienda	2024/12/22 01:13
Prezzo dell'azione a fine giornata	2024/12/20 00:00
Guadagni	2024/09/30
Guadagni annuali	2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

Pacchetto	Dati	Tempistica	Esempio Fonte USA ^*
Dati finanziari della società	10 anni	Conto economico Rendiconto finanziario Bilancio	Modulo SEC 10-K Modulo SEC 10-Q
Stime di consenso degli analisti	+3 anni	Previsioni finanziarie Obiettivi di prezzo degli analisti	Rapporti di ricerca degli analisti Blue Matrix
Prezzi di mercato	30 anni	Prezzi delle azioni Dividendi, scissioni e azioni	Dati di mercato ICE Modulo SEC S-1
Proprietà	10 anni	Top azionisti Insider trading	Modulo 4 SEC Modulo 13D SEC
Gestione	10 anni	Team di leadership Consiglio di amministrazione	Modulo SEC 10-K Modulo SEC DEF 14A
Sviluppi principali	10 anni	Annunci aziendali	Modulo 8-K SEC

^* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .

Fonti analitiche

KPJ Healthcare Berhad è coperta da 28 analisti. 15 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

Analista	Istituzione
Ken-Wern Lim	Affin Hwang Investment Bank
Chee Chow	Affin Hwang Investment Bank
King Cheah	Alliance Research Sdn. Bhd.

KPJ Healthcare Berhad Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 9.3% to RM2.37

Price target increased by 7.4% to RM1.93

Price target increased by 8.3% to RM1.72

Price target increased by 8.6% to RM1.48

Consensus EPS estimates increase by 25%

Price target increased by 8.7% to RM1.23

Recent updates

We Think KPJ Healthcare Berhad (KLSE:KPJ) Can Stay On Top Of Its Debt

Price target increased by 9.3% to RM2.37

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

KPJ Healthcare Berhad's (KLSE:KPJ) Price Is Out Of Tune With Earnings

KPJ Healthcare Berhad (KLSE:KPJ) Has Affirmed Its Dividend Of MYR0.01

Second quarter dividend of RM0.01 announced

KPJ Healthcare Berhad to Report Q2, 2024 Results on Aug 28, 2024

Second quarter 2024 earnings: Revenues exceed analyst expectations

Returns Are Gaining Momentum At KPJ Healthcare Berhad (KLSE:KPJ)

Do KPJ Healthcare Berhad's (KLSE:KPJ) Earnings Warrant Your Attention?

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Price target increased by 7.4% to RM1.93

KPJ Healthcare Berhad Appoints Encik Mohd Khairul Izzad Bin Mohammed Shamsudin as Chief Financial Officer, Effective June 10, 2024

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

First quarter dividend of RM0.01 announced

First quarter 2024 earnings: EPS misses analyst expectations

KPJ Healthcare Berhad, Annual General Meeting, Jun 26, 2024

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

KPJ Healthcare Berhad Announces Resignation of Md Arif Bin Mahmood as Non Independent and Non Executive Chairman, Effective April 1, 2024

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Price target increased by 8.3% to RM1.72

Full year 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Upcoming dividend of RM0.013 per share at 3.0% yield

Price target increased by 8.6% to RM1.48

KPJ Healthcare Berhad to Report Q3, 2023 Results on Nov 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Special Dividend for the Financial Year Ending 31 December 2023

KPJ Healthcare Berhad Announces Appointment of Keh Ching Tyng as Joint Secretary

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kpj Healthcare Berhad Announces Appointment of Mr. Chin Keat Chyuan as President, Effective 1 September 2023

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

KPJ Healthcare Berhad Declares Interim Dividend for the Year Ended December 31, 2023, Payable on July 4, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

Now 22% undervalued

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

Full year 2022 earnings released: EPS: RM0.04 (vs RM0.013 in FY 2021)

Now 23% undervalued

Now 22% undervalued

Now 21% undervalued

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Consensus EPS estimates increase by 25%

Price target increased by 8.7% to RM1.23

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year End December 31, 2023, Payable on April 14, 2023

Now 21% undervalued

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Upcoming dividend of RM0.01 per share

Consensus EPS estimates increase by 30%

Price target increased to RM1.07

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year Ended December 31, 2022, Payable on December 28, 2022

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

KPJ Healthcare Berhad Appoints Encik Hisham Bin Zainal Mokhtar as Independent and Non Executive Member of Risk Committee

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Fiscal Year Ending December 31, 2022, Payable on 21 October 2022

KPJ Healthcare Berhad Announces the Resignation of TEH PENG PENG as Joint Secretary

KPJ Healthcare Berhad Appoints Nantha Kumar Subramanian as Its New Chief Digital Officer

KPJ Healthcare Berhad Appoints Lee Lai Fan as Independent and Non Executive Director

KPJ Healthcare Berhad Announces Retirement of Puan Lydia Anne Abraham as Independent and Non Executive Director

Consensus EPS estimates fall by 17%

High number of new directors